This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Danchenko, N Articles by Anthony, M S Search for Related Content PubMed PubMed Citation Articles by Danchenko, N Articles by Anthony, M S Social Bookmarking                         What's this?

Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden

6 Canal Park, Suite 708, Cambridge, Massachusetts, USA, Natalya_danchenko{at}yahoo.com

J A Satia

Departments of Epidemiology and Nutrition, University of North Carolina at Chapel Hill, USA

M S Anthony

Amgen, Inc., Thousand Oaks, California, USA

Systemic lupus erythematosus (SLE) is a disease of multifactorial etiology. Quantifying the burden of SLE across different countries can clarify the role of genetic, environmental and other causative factors in the natural history of the disease, and to understand its clinical and societal consequences. The aim of this study is to summarize data on SLE incidence and prevalence in the USA, Europe, Asia, and Australia. An extensive review of electronic resources (PubMed and MedLine) and medical journals was conducted to identify published studies on SLE incidence and prevalence over the period of 1950-early 2006. Researchers in the countries of interest provided additional information on the epidemiology of SLE. The incidence and prevalence of SLE varies considerably across the countries. The burden of the disease is considerably elevated among non-white racial groups. There is a trend towards higher incidence and prevalence of SLE in Europe and Australia compared to the USA. In Europe, the highest prevalence was reported in Sweden, Iceland and Spain. There are marked disparities in SLE rates worldwide. This variability may reflect true differences across populations, or result from methodological differences of studies. The true geographic, racial, and temporal differences in SLE incidence and prevalence may yield important clues to the etiology of disease.

Key Words: epidemiology • incidence • lupus • prevalence

Lupus, Vol. 15, No. 5, 308-318 (2006)
DOI: 10.1191/0961203306lu2305xx


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				K. J. COLANGELO, J. E. POPE, and C. PESCHKEN The Minimally Important Difference for Patient Reported Outcomes in Systemic Lupus Erythematosus Including the HAQ-DI, Pain, Fatigue, and SF-36 J Rheumatol, October 1, 2009; 36(10): 2231 - 2237. [Abstract] [Full Text] [PDF]

				A. HELLQUIST, T. M. JARVINEN, S. KOSKENMIES, M. ZUCCHELLI, C. ORSMARK-PIETRAS, L. BERGLIND, J. PANELIUS, T. HASAN, H. JULKUNEN, M. D'AMATO, et al. Evidence for Genetic Association and Interaction Between the TYK2 and IRF5 Genes in Systemic Lupus Erythematosus J Rheumatol, August 1, 2009; 36(8): 1631 - 1638. [Abstract] [Full Text] [PDF]

				W. Yang, M. Zhao, N. Hirankarn, C. S. Lau, C. C. Mok, T. M. Chan, R. W.S. Wong, K. W. Lee, M. Y. Mok, S. N. Wong, et al. ITGAM is associated with disease susceptibility and renal nephritis of systemic lupus erythematosus in Hong Kong Chinese and Thai Hum. Mol. Genet., June 1, 2009; 18(11): 2063 - 2070. [Abstract] [Full Text] [PDF]

				G. Wlasiuk, S. Khan, W. M. Switzer, and M. W. Nachman A History of Recurrent Positive Selection at the Toll-Like Receptor 5 in Primates Mol. Biol. Evol., April 1, 2009; 26(4): 937 - 949. [Abstract] [Full Text] [PDF]

				S. Han, X. Kim-Howard, H. Deshmukh, Y. Kamatani, P. Viswanathan, J. M. Guthridge, K. Thomas, K. M. Kaufman, J. Ojwang, A. Rojas-Villarraga, et al. Evaluation of imputation-based association in and around the integrin-{alpha}-M (ITGAM) gene and replication of robust association between a non-synonymous functional variant within ITGAM and systemic lupus erythematosus (SLE) Hum. Mol. Genet., March 15, 2009; 18(6): 1171 - 1180. [Abstract] [Full Text] [PDF]

				S. Westlake and C. Edwards Anti-malarials and Lupus in West Africa use and lupus in Africans Lupus, March 1, 2009; 18(3): 193 - 195. [PDF]

				J. Mason and D Bossingham The clinical characterisation of systemic lupus erythematosus in a Far North Queensland Indigenous kindred Lupus, February 1, 2009; 18(2): 144 - 148. [Abstract] [PDF]

				C. A. Heyneman Systemic Lupus Erythematosus: A Therapeutic Update Journal of Pharmacy Practice, February 1, 2009; 22(1): 29 - 52. [Abstract] [PDF]